CiToxLAB has increased its inhalation test capabilities in North America and Europe. CiToxLAB-North America has opened a new rodent and non-rodent inhalation facility, adding the ability to evaluate pharmaceuticals, biological compounds and inhalation devices.   The studies conducted at the facility will use seven rodent suites and five non-rodent suites, with capabilities to perform studies by the inhalation route in all species. In CiToxLAB-North America, the Canadian team has more than 25 yea...